back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-03-28 15:35 Tx date 2024-03-28 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,700
+1,000 vol $8.70 each |
9,684 | |
| Filed 2024-03-28 15:32 Tx date 2024-03-28 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,700
+1,000 vol $8.70 each |
8,684 | |
| Filed 2024-03-20 16:00 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$840.72
+113 vol $7.44 each |
8,751 | |
| Filed 2024-03-20 15:59 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,971
+649 vol $7.66 each |
8,638 | |
| Filed 2024-03-20 15:55 Tx date 2024-01-04 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,222
+136 vol $8.99 each |
||
| Filed 2024-03-20 15:55 Tx date 2023-12-20 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$61.95
+7 vol $8.85 each |
||
| Filed 2024-03-20 15:55 Tx date 2023-10-13 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,218
+151 vol $8.07 each |
||
| Filed 2024-03-20 15:55 Tx date 2023-09-19 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$54.95
+7 vol $7.85 each |
||
| Filed 2024-03-20 15:55 Tx date 2023-07-06 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,145
+153 vol $7.49 each |
||
| Filed 2024-03-20 15:54 Tx date 2023-06-20 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$43.86
+6 vol $7.31 each |
||
| Filed 2024-03-20 15:54 Tx date 2023-04-11 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,221
+161 vol $7.59 each |
||
| Filed 2024-03-20 15:54 Tx date 2023-03-17 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$36.50
+5 vol $7.30 each |
||
| Filed 2024-03-20 15:53 Tx date 2023-01-18 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,130
+151 vol $7.49 each |
||
| Filed 2024-02-09 14:04 Tx date 2024-01-04 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,222
+136 vol $8.99 each |
||
| Filed 2024-02-09 14:01 Tx date 2023-12-20 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$61.95
+7 vol $8.85 each |
||
| Filed 2024-02-09 13:59 Tx date 2023-10-13 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,218
+151 vol $8.07 each |
||
| Filed 2024-02-09 13:57 Tx date 2023-09-19 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$54.95
+7 vol $7.85 each |
||
| Filed 2024-02-09 13:56 Tx date 2023-07-06 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,145
+153 vol $7.49 each |
||
| Filed 2024-02-09 13:54 Tx date 2023-06-20 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$43.86
+6 vol $7.31 each |
||
| Filed 2024-02-09 13:53 Tx date 2023-04-11 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,221
+161 vol $7.59 each |
||
| Filed 2024-02-09 13:50 Tx date 2023-03-17 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$36.50
+5 vol $7.30 each |
||
| Filed 2024-02-09 13:48 Tx date 2023-01-18 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,130
+151 vol $7.49 each |
||
| Filed 2024-01-06 08:38 Tx date 2024-01-02 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$9,540
+1,066 vol $8.95 each |
6,922 | |
| Filed 2024-01-06 08:31 Tx date 2024-01-02 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-2,133 vol |
5,856 | |
| Filed 2023-10-05 17:51 Tx date 2023-10-02 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$8,339
+1,061 vol $7.86 each |
7,989 | |
| Filed 2023-10-05 17:48 Tx date 2023-10-02 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-2,123 vol |
6,928 | |
| Filed 2023-07-04 12:38 Tx date 2023-06-30 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$7,909
+1,056 vol $7.49 each |
9,051 | |
| Filed 2023-07-04 12:36 Tx date 2023-06-30 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-2,112 vol |
7,995 | |
| Filed 2023-04-01 12:17 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,051 vol |
10,107 | |
| Filed 2023-04-01 12:15 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-2,102 vol |
9,056 | |
| Filed 2023-03-20 11:34 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$332.29
+47 vol $7.07 each |
11,158 | |
| Filed 2023-03-20 11:32 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,444
+531 vol $8.37 each |
11,111 | |
| Filed 2022-03-21 07:14 Tx date 2021-12-31 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,060
+270 vol $7.63 each |
10,580 | |
| Filed 2020-04-05 09:34 Tx date 2020-03-31 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$29,999
+8,310 vol $3.61 each |
10,310 | |
| Filed 2019-03-28 Tx date 2019-03-25 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,680
+2,000 vol $7.34 each |
2,000 | |
| Filed 2019-03-28 Tx date 2018-01-08 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-03-28 Tx date 2019-03-25 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,340
+1,000 vol $7.34 each |
||
| Filed 2018-01-11 Tx date 2018-01-08 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-01-11 Tx date 2018-01-08 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$31,152
+3,245 vol $9.60 each |
3,245 | |
| Filed 2018-01-11 Tx date 2018-01-08 |
$RX
BioSyent Inc. |
Andrews, Larry
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
00 - Opening Balance-Initial SEDI Report
|